CD4
+ T cells are essential for host defence, as exemplified by the effects of the CD4 + T cell depletion that is associated with HIV infection and AIDS. This loss of T cells leads to a profound impairment of the immune response and a range of opportunistic infections. Conversely, CD4 + T cells are also fundamental drivers of autoimmunity when a loss of tolerance occurs. CD4 + T cells mainly direct immune responses through the cytokines they produce, and our understanding of the range of cytokines produced by CD4 + T cells has increased considerably 1 . In addition to T helper 1 (T H 1) and T H 2 cells, which produce interferon-γ (IFNγ) and interleukin-4 (IL-4), respectively, new subsets of T cells continue to be recognized. These include regulatory T (T Reg ) cells 2 , of which there are both natural and induced subsets, and IL-17-producing [2] [3] [4] , IL-9-producing 5-7 and IL-22-producing T H cells 7, 8 . In addition, IL-21-producing follicular helper T (T FH ) cells provide help to B cells, but their identity as a distinct 'lineage' and their relationship to other CD4 + T cell subsets remain a source of some controversy 9, 10 . What is clear is that the cytokine milieu is crucial for CD4 + T cell differentiation. Signal transducer and activator of transcription (STAT) family proteins have essential roles in transmitting many cytokine-mediated signals and therefore have similarly crucial roles in T H cell differentiation 1, 11 . The first STAT proteins to be discovered (STAT1 and STAT2) were identified as inducers of de novo gene transcription in response to inter ferons (IFNs) 12, 13 . Since then, the essential, non-redundant functions of the seven members of the STAT family have been extensively defined by generating individual gene knockout mice and by careful analysis of the effects on gene expression [14] [15] [16] [17] [18] . One of the challenges to interpreting such gene expression data is to distinguish the direct actions of STATs on individual genes from secondary, indirect effects of STAT deficiency. Recent technologies have enabled investigators to construct a genome-wide view of transcription factor binding to distinguish direct from indirect effects.
In this Review, we discuss the impact of next-generation sequencing 19, 20 , and illustrate how this technology has allowed us to begin to construct a quantitative map, not only of genome-wide transcription factor binding but also of the effects on genome-wide epigenetic changes. Specifically, we review the genome-wide STAT binding studies that have been reported so far. We discuss the relationship between STAT binding and local epigenetic patterns, and consider how STAT proteins can integrate extrinsic signals to influence epigenetic changes associated with T cell lineage commitment. Finally, we review emerging new information regarding mutations and polymorphisms of STAT genes that are associated with human immune disorders.
New technology and genome-wide views
STATs are transcription factors that induce the transcription of their target genes by recognizing and binding specific DNA consensus sequences. The direct binding of STATs to DNA was initially analysed by electrophoretic mobility shift assays. Later, analysis of STAT binding to specific genes was carried out using Chromatin immunoprecipitation (ChIP) . A technique used to detect the DNA binding sites of specific proteins within chromatin. These assays involve chemical crosslinking of the bound proteins to the DNA, followed by immunoprecipitation with an antibody that is specific for the protein of interest.
Epigenetic regulation
The heritable, but potentially reversible, states of gene activity that are imposed by the structure of chromatin, such as covalent modifications of DNA or of nucleosomal histones. The epigenome pertains to the aspects of heritable cellular phenotype that are not explained by DNA sequence.
Nucleosome
A nucleosome consists of a core of histone proteins with a segment of DNA wrapped around it. It is the minimum unit required to make up a chromosome.
ChIP-seq
A technique in which chromatin immunoprecipitation is followed by high-throughput sequencing to generate a genome-wide distribution map of protein-DNA interactions. This technique can be used to measure transcription factor binding or histone modifications.
chromatin immunoprecipitation (ChIP) followed by PCRbased detection of precipitated DNA using primers specific for pre-selected regions. The application of this type of targeted analysis was inevitably limited to a small subset of genes and regions. However, with the arrival of next-generation sequencing methods, an unbiased genome-wide view of protein-DNA association has become a reality FIG. 1 ), allowing us to catalogue the entire range of STAT target genes on a genome-wide scale. Equally important has been the capability to map histone epigenetic marks throughout the entire genome to gain an insight into how chromatin accessibility relates to STAT binding and ultimately to transcriptional regulation.
Evolving views of the epigenome. It has become clear since the original discovery of the STATs that, in addition to transcription factor binding, a crucial part of gene regulation is epigenetic regulation and that the modifications comprised by this term are highly dynamic 21 . It is beyond the scope of the present Review to comprehensively discuss this incredibly active field but, briefly, factors that influence the accessibility of chromatin for active transcription include DNA methylation, ATPdependent nucleosome remodelling and a large number of post-translational histone modifications. Acting together with transcription factors, these chromatin modifications have major effects on gene expression [22] [23] [24] . Early genome-wide maps of histone modifications generated by ChIP-seq (ChIP followed by high-throughput sequencing) suggested novel functions for histone modifications and showed the importance of combinatorial patterns of modifications 25, 26 . Although acetylation is always associated with active chromatin regions, the functional significance of histone methylation with respect to gene expression is more complex. For example, trimethylation of histone H3 lysine 4 (H3K4), H3K36
and H3K79 is associated with active genes (so these modifications are known as 'permissive' marks), whereas dimethylation or trimethylation of H3K27, H3K9 and H4K20 is linked to gene silencing (and these are known as 'repressive' marks). Importantly, in contrast to classic views of the epigenome, it is now clear that some of these modifications can occur rapidly in response to exogenous signals [27] [28] [29] . Therefore, the nucleosome is increasingly viewed as a nuclear sensor that responds to various signals from the cellular environment.
Cytokine signalling and the T cell epigenome. The ability to measure genome-wide changes in histone modifications by ChIP-seq provided an opportunity to ask a simple but crucial question about T cell biology, namely whether the observed epigenetic modifications in T cells are more consistent with a model of stable terminal differentiation of CD4 + T cells or with intrinsic flexibility in T cell responses 6, 7 . The stability of various T cell subsets continues to be intensively debated, and striking examples of T cell plasticity have appeared in the literature 30, 31 . In this regard, measuring the epigenetic landscape of T H cells has proved to be illuminating.
Genome-wide maps of H3K4 (permissive) and H3K27 (repressive) trimethylation in naive CD4 + T cells and fully polarized T H 1, T H 2, T H 17, induced T Reg and natural T Reg cells have now been obtained 32 . The data show that the histone modifications of genes encoding signature cytokines of particular T H cell subsets are consistent with a model of terminal commitment, such that permissive marks on a particular cytokine gene are selectively present in the relevant lineage that expresses that cytokine and repressive marks are present in other CD4 + T cell lineages that do not express the cytokine. However, genes encoding 'master regulator' transcription factors, such as Tbx21 (T-box 21) for T H 1 cells and Gata3 (GATA binding protein 3) for T H 2 cells, were found to have 'bivalent Box 1 | Genome-wide chromatin immunoprecipitation to study protein-DNA interactions Chromatin immunoprecipitation (ChIP) has been used to profile protein-DNA interactions. By choosing appropriate antibodies specific for the protein or epigenetic modification of interest, both transcription factor binding and histone epigenetic marks can now be profiled on a genome-wide scale. After protein-associated DNA fragments have been enriched and purified through immunoprecipitation, the DNA fragments can be measured and mapped to reference genomes by either hybridization (in ChIP-on-chip techniques) or high-throughput next-generation sequencing (in ChIP-seq procedures).
ChIP-on-chip, which is based on microarray hybridization technology 133, 134 , has the intrinsic limitation that only pre-selected regions of the genome are included in the arrays, such as proximal gene promoter regions. Also, array-based methods are restricted by the variation and limitations implicit in nucleotide hybridization. By contrast, ChIP-seq covers the entire genome without any preconceived bias 19, 20, 135 . Because the DNA fragments of interest are sequenced directly instead of being hybridized to microarray chips, ChIP-seq provides higher resolution, greater genomic coverage, fewer artefacts and a larger dynamic range of signal strength than ChIP-on-chip. Although the relatively short reads (35-75 base pairs) generated by various next-generation sequencing platforms could pose technical difficulties for certain other applications, such as RNA-seq, the technology is well suited for a ChIP-seq approach 136 . In addition to mapping transcription factor binding and histone epigenetic marks, ChIP-seq has been applied to map the binding of CCCTC-binding factor (CTCF), which regulates chromatin architecture, and histone acetyltransferase p300, which marks enhancer elements 27 . This next-generation sequencing platform is also used to define nucleosome positioning and accessibility by coupling with micrococcal nuclease digestion (MNase-seq) 137 or with the detection of DNase hypersensitivity sites (DNase-seq) 138, 139 . Another application is comprehensive methylome (DNA methylation) mapping 140 , which will provide further insights into the stable and heritable aspects of the epigenome. Finally, next-generation sequencing has been used to profile various types of RNA, including microRNAs 141, 142 , long non-coding intervening RNAs 143 and enhancer RNAs 144 .
poised domains' , meaning that both permissive and repressive histone marks are present in the lineages of alternative fates 32 . Bivalent domains were originally identified in stem cells and they seem to allow for flexibility in gene expression once a cell receives signals for differentiation 33, 34 . Bivalent domains were also found to be present on genes encoding other key transcription factors, including Runx3 (runt-related transcription factor 3), Bcl6 (B cell lymphoma 6) and Blimp1 (B lymphocyteinduced maturation protein 1; also known as Prdm1) 32 . Thus, the answer to the question initially posed is that epigenetic analysis has provided evidence for both terminal commitment (in the case of cytokine genes) and flexible plasticity (in the case of master regulator genes) of T H cells, depending on which genes are examined. As such, the extent to which T cell subsets really behave as 'lineages' or as flexible populations will continue to be the focus of ongoing research and controversy.
Although many interesting observations have arisen from this genome-wide epigenetic profiling 32 , many other questions remain. First, the cell preparation used for these studies was generated in vitro and characterized at a single time point. The dynamic nature of chromatin remodelling and modification over the course of T cell differentiation is yet to be fully elucidated by genome-wide assays. It will be interesting to determine whether the bivalent marks noted on the master transcriptional regulator genes are already in place in the very early phases of T H cell differentiation to guide the transcriptional programme or whether these marks gradually develop over time. Equally, it will be crucial to determine how the recruitment of STAT proteins affects the deposition or removal of epigenetic marks, and how all the aspects of nucleosome remodelling are acquired over time. We also do not yet know the degree of similarity between in vitro-generated cells and bona fide T H cells that arise in vivo during the course of infection or autoimmunity in mice or in humans.
Profiling of genome-wide STAT binding. Initial work using ChIP-seq to map STAT1 binding sites in the genome revealed more than 11,000 sites in unstimulated HeLa cells and 40,000 sites after IFNγ stimulation 35 . However, it was not clear from these data whether STAT1 is an important initiator of gene regulation in all cases of binding or whether STAT1 has a major role in creating the local epigenetic patterns around these binding sites. Subsequent work showed that for most genes, deposition of the local histone modifications preceded ligandinduced STAT1 binding 36 . Although this study was an important breakthrough, it will be important to analyse STAT1 action in various primary cells and to link transcriptional and epigenetic changes using STAT1-deficient cells (discussed further below). Since these initial reports, all STATs (with the exception of STAT2) have been profiled by ChIP-seq, and the original datasets are publicly available through the Gene Expression Omnibus (GEO) repository, as shown in TABLE 1. These datasets will provide an enormous resource to promote further genomic research in the scientific community, and the deposition of original datasets to publicly accessible domains such as GEO will be crucial for future discoveries. However, it will be important to bear in mind the degree of compatibility between different datasets (which have been generated by different sequencing platforms and by different investigators under different experimental conditions), as this could impose certain limitations on comparable analysis. As the field matures, we await better ways to control the 'quality' of these sequencing datasets, including the use of appropriate reference controls to score ChIP-seq peaks 37 , to allow broader across-the-board analyses. Nevertheless, from the STAT binding data A technique to combine chromatin immunoprecipitation with next-generation sequencing to map protein-DNA interactions across the whole genome is shown. Chemically crosslinked protein-DNA complexes are immunoprecipitated and the protein-bound DNA fragments are isolated. The crosslinks are reversed, and the purified DNA is used to generate a library for sequencing. Automated reactions yield more than 20 million sequence reads of 36 nucleotides from each sample (using the Illumina Genome Analyzer platform). The sequence reads are aligned onto the reference genome and the distribution of protein-DNA interaction sites is visualized as 'peaks' on the genome browser.
ChIP-on-chip
A technique that combines chromatin immunoprecipitation (ChIP) with microarray technology ('chip') to investigate protein-DNA interactions in vivo on a genome-wide basis.
Enhancer element
A control element in DNA that is bound by regulatory proteins that influence the rate of transcription of the associated gene(s). Enhancers function in an orientation-and positionindependent manner, so they can be located either upstream or downstream of the associated gene, or in an intron.
listed in TABLE 1, we can start to address the unique as well as shared functions of individual STAT proteins in directing epigenetic modifications and gene expression in T cells. For the sake of brevity, we discuss only the studies listed in TABLE 1 that provide data derived from T cells.
STAT4 in T H 1 cells
Landscape of STAT4 targets. Unlike other STATs, which are expressed by a wide range of cell types, STAT4 is predominantly expressed by immune cells and the testis. Accordingly, its non-redundant functions are manifested mainly in immune cells, resulting in a very discrete phenotype of STAT4 deficiency involving decreased IFNγ production 38 . STAT4 is activated mainly by IL-12, IL-23 and type I IFNs, and it functions predominantly in promoting T H 1 cell differentiation. STAT4 is also the major regulator of Ifng expression in innate immune cells such as natural killer (NK) cells 39, 40 . Before the advent of genomic approaches, only a limited number of direct STAT4 target genes had been identified (including Ifng, Il18r1 (IL-18 receptor 1), Hlx (H2.0-like homeobox), Map3k8 (mitogen-activated protein kinase kinase kinase 8) and Furin). The first effort to increase our knowledge of STAT4 target genes was through the use of ChIP-on-chip technology, which showed that STAT4 bound the promoters of many previously unidentified target genes, such as Gadd45g (growth arrest and DNA-damage-inducible 45γ), Lcp2 (lymphocyte cytosolic protein 2) and Myd88 (myeloid differentiation primary response gene 88) 41 . The expanded list of STAT4 target genes also showed that not all genomic STAT4 binding events are equal. In some cases the binding of STAT4 to a target gene following IL-12-mediated stimulation was not translated into a change in gene expression. Thus, binding per se is not the only determinant of STAT4-dependent gene programming during T H 1 cell differentiation.
Whereas the analysis provided by ChIP-on-chip technology is limited to predefined regions of the genome, ChIP-seq data generate an unbiased genome-wide map of where STATs bind. Using ChIP-seq, STAT4 was found to have 10,000 binding sites in in vitrodifferentiated murine T H 1 cells, 40% of which were localized to the promoters or gene bodies of approximately 4,000 annotated genes 42 . 60% of the STAT4 binding sites occurred in intergenic regions, where some distal enhancer elements are thought to reside, away from annotated genes. In sharp contrast to the implications of the STAT1 data described above, comparative epigenomic analysis of wild-type versus STAT4-deficient T H 1 cells provided evidence that of the ~4,000 genes bound by STAT4, nearly 1,000 had STAT4-dependent alterations in epigenetic modifications. And of these 1,000 genes, 200 had highly STAT4-dependent gene expression, as determined by microarray analysis of wild-type versus STAT4-deficient cells. These genes therefore represent a core subset of direct STAT4 targets that are highly dependent on STAT4 for promoting gene expression and the local epigenetic signature. Importantly, their dependence on STAT4 cannot be compensated for by other STAT proteins or transcription factors. This gene subset included not only signature T H 1 cell genes, such as Ifng and Tbx21, but also others, including Il18rap (IL-18 receptor accessory protein), Icos (inducible T cell co-stimulator), Lilrb4 (leukocyte immunoglobulin-like receptor B4) and Nkg7 (NK group 7). This implies a potential role for these genes in maintaining the phenotype of fully polarized T H 1 cells, and this might be of interest to examine in the future.
The analysis of STAT4 target genes also showed that some cytokine genes that were previously considered to define other T H cell lineages were targets of STAT4 in T H 1 cells. Although it was initially denoted as a T H 2 cell cytokine in mice, subsequent work has shown that IL-10 is expressed by multiple T cell subsets 43 . It was interesting to note that the Il10 gene was bound and positively regulated by STAT4 in T H 1 cells, but also by STAT6 in T H 2 cells. Similarly, IL-21 was initially noted to be a product of T cells following T cell receptor stimulation, but was later reported to be produced by T H 17 cells in a STAT3-dependent manner [44] [45] [46] [47] . More recently, IL-21 has also been reported as a lineage-defining cytokine for T FH cells 10 . However, ChIP-seq data have indicated that STAT4 can bind and regulate the Il21 gene, and this is consistent with the recent finding that IL-12 (which signals through STAT4) can induce the expression of IL-21 in human T cells 48 . Thus, Il10 and Il21 are two examples of genes that can be regulated by multiple STATs.
STAT4 as a transcriptional repressor. Generally, transcription factors that drive lineage commitment positively regulate the expression of phenotype-defining genes, but they can also repress the expression of genes associated with alternative fates. Although STATs were originally discovered as activators of gene transcription and genome-wide analysis has confirmed that they function in this way, there have been indications that STATs can also have roles as functional repressors. Microarray data have provided evidence that the expression of certain genes is increased when a given STAT is deleted 49, 50 , but there are few examples of genes for which STATs seem to function as direct transcriptional repressors 51, 52 . In this regard, several possible ways in which a STAT protein could cause gene silencing have been reported, including the recruitment of DNA methyltransferase 1 (DNMT1) and histone deacetylase 1 (HDAC1) 53 or direct interaction with heterochromatin protein 1 (HP1) for heterochromatin formation 54 . In T H 1 cells, STAT4-dependent repressive histone marks have been identified on several T H 2 cell-expressed genes, including STAT6 target genes, which are actively repressed by STAT4 in T H 1 cells. Although the total number of such genes is small (~40 genes), the data clearly point to a role for STAT4 as a transcriptional repressor, in addition to its more widely recognized role as a transcriptional activator (FIG. 2) . It is not yet clear how a transcription factor can drive expression of one gene and repress the expression of another gene in the same cell, but it will be informative to analyse the associating factors and proteins that are locally recruited to genes that are bound and repressed by STAT proteins. The successful identification of specific chromatin modifications that are associated with STAT binding 42 is a different way of using the genomic approach, aside from obtaining a list of target genes. A genomic approach that integrates different types of read-out enables us to 'examine the forest' rather than just 'finding the trees' in the genome. Not to say that the trees are not interesting, but the big picture is important as well.
STAT6 in T H 2 cells
STAT6 as a driver of T H 2 cell differentiation. T H 2 cell differentiation is induced by IL-4, and the importance of STAT6 for this process has been well established in mice [55] [56] [57] [58] . The actions of STAT6 and its downstream targets in pathological T H 2 cell responses such as asthma and allergy are also of great interest, given the public health impact of these diseases. Consequently, the functions of STAT6 have been studied in both mouse 16, 18 and human 59 systems. In human cells, STAT6 mediates the expression of more than 80% of IL-4-regulated genes, a higher proportion than was reported in previous studies using mouse cells 16 . The functions and cellular distributions of identified STAT6 targets are varied, reflecting the fundamental role of STAT6 in regulating multiple cellular activities.
Genome-wide kinetic profiling of STAT6-dependent gene expression and analysis of the STAT6-dependent gene network in humans 59 confirm that STAT6 is a major, direct contributor to the transcriptional profile associated with the T H 2 cell phenotype. The findings also show that IL-4-induced regulation of gene transcription in human cells is highly dynamic; only a subset of the genes that were differentially regulated within the first few hours after IL-4 treatment remained differentially expressed at later time points up to 72 hours. Thus, soon after IL-4 treatment, STAT6 is a major 'switch signal' to initiate the T H 2 cell differentiation programme, but at later points other factors in addition to STAT6 are required to maintain the acquired T H 2 cell phenotype. Genome-wide differential gene expression analysis using small interfering RNA (siRNA) identified 453 genes that are regulated by STAT6 in human cells 59 . Only 6% of these genes had been previously identified as STAT6 targets, including GATA3, SOCS1 (suppressor of cytokine signalling 1) and IL24. The new target genes indicate new functions and processes that might be mediated by STAT6 signalling. In general, the findings underscore the importance of using genome-wide approaches to explore the species-specific roles of STAT proteins in humans and mice.
The early signalling network: connection to different T H cell fates. By gene network analysis, the transcription factors regulated by IL-4 and STAT6 were found to form a compact core interaction network of signalling 59 (FIG. 3) . These data highlight the importance of combinatorial signalling pathways that function together to determine T H cell commitment and fate. Of the newly identified direct STAT6 targets, three transcription factors that form hubs in the regulatory network are of particular interest: RUNX1, EPAS1 (endothelial PAS domain protein 1) and BATF (basic leucine zipper transcriptional factor ATF-like). RUNX proteins have a central role in regulating T H cell differentiation in general 60 , but RUNX1 preferentially inhibits T H 2 cell differentiation by downregulating GATA3 expression 61 and by binding to the IL4 silencer region 62 . In addition, RUNX1 can form a complex with forkhead box P3 (FOXP3) or retinoic acid receptor-related orphan receptor-γ (RORγ; encoded by RORC), and these interactions are necessary for T Reg and T H 17 cell function, respectively 63, 64 . Interestingly, EPAS1 binds to the RUNX1 promoter, potentially amplifying the effect of STAT6 on RUNX1 expression 65 . BATF, which is also a direct target of STAT6, regulates both T H 17 and T H 2 cell differentiation 66, 67 . The connection between the T H 2 cell differentiation programme and the programmes for other T H cell subsets can be further examined through the network of key transcription factors. It is notable that within the STAT6-mediated T H 2 cell differentiation programme there are close connections between STAT6 and other STAT family proteins involving only a few intermediate molecules, as shown in FIG. 3 they have overlapping targets and thus indicated that these two STATs might have cooperative roles 59 . This is consistent with the known contribution of STAT5 to STAT6-independent T H 2 cell commitment [68] [69] [70] . A stabilizer of the T H 2 cell phenotype. The crucial role of STAT6 in the initiation stage of T H 2 cell differentiation is evident, but STAT6 also contributes to the maintenance of the T H 2 cell phenotype in differentiated cells. This conclusion has been supported by a combinatorial genome-wide analysis of STAT6 binding and STAT6-induced epigenetic patterns and gene expression 42 . Similarly to STAT4, STAT6 is responsible for the maintenance of distinct epigenetic patterns on selected target genes. STAT6 mainly functions as a transcriptional activator but, as is the case with STAT4, it is also a functional repressor for a subset of genes. In terms of activating target genes, STAT6 more frequently opposes the deposition of repressive epigenetic marks than it promotes permissive epigenetic marks; in this regard, STAT6 seems to be subtly different from STAT4.
Of particular interest is a subset of genes that are bound by STAT4 in T H 1 cells but by STAT6 in T H 2 cells, for which the two STATs have opposing effects on local epigenetic patterns. A notable example is the Il18r1-Il18rap locus 42 . So, whereas one STAT (in this case STAT4) promotes permissive marks, the other STAT (STAT6) promotes repressive marks on the same locus. This divergent action of STAT4 and STAT6 on the same genes provides an insurance for inducing gene expression in one lineage and repressing gene expression in the other lineage (FIG. 2) .
STAT3 and T H 17 cell differentiation
T H cells that selectively produce IL-17 (known as T H 17 cells) are one of the newest T cell subsets to be recognized. They have crucial roles in host defence against extracellular bacteria and fungi, but also in the pathogenesis of various autoimmune diseases 2, 3 . Cytokines that promote IL-17 production include IL-1, transforming growth factor-β1 (TGFβ1), IL-6, IL-21 and IL-23. The last three of these cytokines activate STAT3. Although STAT3 is activated by a large number of cytokines and has crucial functions in various tissues 71, 72 , T cellspecific deletion of STAT3 mainly affects the expression of IL-17 and IL-21 , and consequently results in decreased severity of several autoimmune disease models 73, [76] [77] [78] [79] . Conversely, an increase in STAT3 activation, through the deletion of Socs3, results in increased numbers of T H 17 cells 74 .
Landscape of STAT3 targets. ChIP-seq analysis of STAT3 binding in T cells, coupled with gene expression analysis, has confirmed that the Il17 and Il21 genes are direct targets of STAT3 (REFS 46, 74, 76) . Of note, STAT3 binds to multiple sites in the Il17 locus 80 , the most prominent of which are intergenic regions that coincide with conserved non-coding sequences (CNS) 81 . These sites also bind histone acetyltransferase p300 and so are probably enhancer elements (G.V., Y.K. and J.J.O'S., unpublished observations). Furthermore, in an analogous role to that of STAT6 in T H 2 cells, STAT3 directly binds to multiple genes encoding transcription factors that are crucial for programming T H 17 cells. These include Rorc 82 , Rora 83 , Ahr (aryl hydrocarbon receptor) 84 , Batf 66 , Irf4 (interferon regulatory factor 4) 85 and Maf
86
. Other important direct targets of STAT3 that define the T H 17 cell phenotype include Il23r and Il6ra 45, 76 . Notably, the ability of STAT3 to positively regulate the expression of these genes is associated with the presence of permissive H3K4me3 marks. The prominent role of STAT3 in the specification of T H 17 cells led to a re-evaluation of the factors involved in this process. Although TGFβ signalling is usually required for T H 17 cell differentiation, an alternative mode of T H 17 cell generation that can occur in the absence of TGFβ has also been recognized 87 . It was found that activation of STAT3 together with IL-1 was sufficient to promote expression of IL-23R 87 . Acquisition of this receptor by T cells allowed responsiveness to IL-23, which has a major role in driving pathogenic IL-17-dependent responses 88 . Thus, pathogenic T H 17 cells were generated in the absence of TGFβ signalling 87 through the activation of STAT3 and other cooperating factors. In this regard, it is interesting that genome-wide STAT3 binding sites overlap significantly with those for IRF4 after IL-21 stimulation 89 . In addition to confirming the role of STAT3 in regulating the expression of T H 17 cell-related cytokines and transcription factors, ChIP-seq analysis has pointed to a role for STAT3 in regulating T cell proliferation and survival. Newly identified STAT3 target genes in T cells that might mediate these functions include the anti-apoptotic genes Bcl2 and Ier3 (immediate early response 3), and the proto-oncogenes Fos, Jun and Fosl2. Although no phenotypical evidence for this function was reported in the initial description of STAT3 deletion in T cells 90 , the delayed proliferation and poor clonal expansion of Stat3 76 , which is consistent with the relief of IL-6-mediated inhibition of T Reg cells. Curiously, when Stat3 was deleted only in the T Reg cell population, the ability of T Reg cells to constrain a pathogenic T H 17 cell response was selectively impaired, whereas suppression of T H 1 or T H 2 cell responses remained intact 92 . These data indicate that intrinsic activation of STAT3 in T Reg cells endows these cells with the ability to specifically suppress T H 17 cell responses. Gene expression analysis of STAT3-deficient T Reg cells showed impaired expression of genes potentially contributing to the suppressor function of T Reg cells. These genes included Prf1 (perforin 1), Gzmb (granzyme B), Klrg1 (killer cell lectin-like receptor G1), Ccr6 (CC-chemokine receptor 6), Il1r1 and Il6ra. As additional ChIP-seq datasets are generated, it will be of considerable interest to dissect how STAT3 controls T Reg cell-mediated suppression of specific T H cell subsets.
Genome-wide association study
A study in which genome-wide genetic variation is linked to a particular phenotype, most often a clinical disorder, by applying high-throughput genotyping techniques to profile single nucleotide polymorphisms (SNPs) of control subjects compared with patients.
STAT5 and T Reg cell differentiation
Essential regulators of lymphoid development and peripheral tolerance. The STAT5A and STAT5B genes are adjacent on the same chromosome in both mice and humans, have 96% sequence similarity and have overlapping functions in diverse tissues 93, 94 . Similarly to STAT3 deficiency, germline deletion of Stat5a and Stat5b (collectively referred to as Stat5) is embryonic lethal 95, 96 . The few mice that survive are extremely runted and anaemic. Stat5 deletion has marked effects on all lymphoid lineages, including T cells (thymic and peripheral), B cells and NK cells, pointing to a crucial role for STAT5 in lymphoid development. It should also be noted that the targeted disruption of Stat5a or Stat5b individually yields distinct phenotypes, which indicates that there are signalling mechanisms unique to each 94 . The target genes of STAT5 in T cells 68 and other cells have been elucidated using ChIP-seq. These data have helped to explain the role of STAT5 in T H 2 cell differentiation by showing that STAT5 upregulates expression of the IL-4 receptor 68 . However, there has been remarkably little analysis so far of the non-redundant roles of STAT5 in regulating the development and survival of T cells. Given the profound effects of STAT5 deficiency in T cells, more extensive analysis of the STAT5 ChIP-seq datasets is warranted.
The few peripheral T cells that develop in STAT5-deficient mice have an activated phenotype, and this leads to the development of autoimmunity [97] [98] [99] . One major factor underlying this autoimmune phenotype is impaired T Reg cell development in both the thymus and the periphery owing to deletion of Stat5 in CD4 + T cells. Indeed, STAT5 binds to the promoter and first intron of the Foxp3 gene to activate transcription of this T Reg cell master regulator 95, 96, 100 . In addition, STAT5 influences the survival of T Reg cells by regulating the expression of the IL-2R α-chain (also known as CD25) and the anti-apoptotic protein BCL-2. Although it is probable that STAT5 regulates many aspects of lymphoid survival, a direct comparison of STAT5 target genes in T Reg cells and conventional CD4 + T cells has not been carried out. Equally, a direct comparison of STAT5 and STAT3 target genes in T Reg cells would be particularly interesting.
Whereas IL-2-mediated activation of STAT5 results in the upregulation of FOXP3 expression, which is indispensable for the maintenance of T Reg cells, other STATs negatively influence FOXP3 expression. For example, IL-4-mediated STAT6 activation, IL-12-mediated STAT4 activation and IL-6-mediated STAT3 activation all decrease the expression of FOXP3 and affect chromatin modification at the Foxp3 locus 73, 95, 101, 102 . However, the exact mechanisms by which STAT4 and STAT6 function to negatively regulate T Reg cells have not been elucidated on a genome-wide scale.
Similarly to how the activation of STAT4 and STAT6 determines T H 1 versus T H 2 cell differentiation, the activation of STAT5 and STAT3 seems to dictate the dichotomy of T Reg cells and T H 17 cells 80 . In addition to its role in positively regulating T Reg cell function, STAT5 inhibits T H 17 cell differentiation 103 . To address the potential mechanisms underlying this action, mapping of STAT5 targets in IL-2-activated T H 17 cells was carried out by ChIP-seq. One important finding was the extensive overlap between STAT3 and STAT5 binding sites in the Il17 gene 80 . It was found that STAT5 competes with STAT3 for binding to Il17 and inhibits the function of STAT3 in activating Il17 transcription. The opposing effects of STAT3 and STAT5 on Il17 transcription explain why IL-2 inhibits IL-17 production, although the effects of other signalling molecules that are activated by these distinct cytokines might also contribute to this phenotype. In many other cases, it is probable that STAT3 and STAT5 work together to enhance gene expression but, given the example of Il17, it is clear that these two highly related transcription factors can act in opposition. Exactly how these factors can accomplish global versus gene-specific effects warrants further investigation.
STATs and human disease
In addition to abundant data pointing to crucial functions of STAT proteins in animal models, evidence of the importance of STATs in humans is quickly emerging from studies of patients with primary immunodeficiency and autoimmune diseases.
New insights into primary immunodeficiency disorders.
Previous work has established that STAT5 mutations in humans are associated with impaired T Reg cell function 104 and that STAT1 mutations are associated with susceptibility to viral and mycobacterial infections 105, 106 . Furthermore, recent work has established that another classic primary immunodeficiency, hyper-IgE syndrome (HIES; also known as Job's syndrome), is a result of dominant-negative mutations of STAT3 (REFS 107, 108) . This finding was interesting because germline deletion of Stat3 in mice is embryonic lethal. Thus, the restricted pathology seen in humans with STAT3 mutations was not anticipated. Presumably this is because the mutant allele interferes with but does not totally abrogate STAT3 function. A classic feature of HIES is infection without the typical signs of inflammation (such as redness and warmth), resulting in 'cold abscesses' . It is tempting to speculate that this unique feature of HIES is related to the absence of T H 17 cells in this disorder [109] [110] [111] [112] , as the lack of IL-17 would lead to a failure to recruit neutrophils to sites of infection. It remains to be elucidated how the impaired function of STAT3 in other tissues contributes to the pathology seen in HIES in various tissues.
Genetic polymorphisms and human autoimmunity.
Although various animal models have implicated STATs and altered cytokine signalling in autoimmunity, the issue always arises as to whether these models really mirror immunopathogenic mechanisms in humans. However, large-scale genome-wide association studies have now provided evidence that various genes involved in cytokine signalling, and STATs in particular, are linked to the development of autoimmunity in humans (TABLE 2) . For example, polymorphisms in STAT3 are linked to susceptibility to Crohn's disease (a form of inflammatory bowel disease) and ankylosing spondylitis 113, 114 . Equally compelling is the evidence that polymorphisms of IL23R and JAK2 (Janus kinase 2) are linked to the same diseases [115] [116] [117] [118] [119] [120] , suggesting a profound involvement of the IL-23-STAT3 axis in the genesis of autoimmune diseases.
In multiple studies, a variant allele of STAT4 has been found to be associated with an increased risk of developing systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjögren's syndrome and Crohn's disease [121] [122] [123] . The connection between STAT4 and SLE is perhaps unexpected insofar as this disease is not a prototypical T H 1 cell-mediated disease. However, it is worth noting that STAT4 can be activated by type I IFNs 124 , and an important aspect of the pathogenesis of SLE is the 'interferon signature' 125 . Polymorphisms in TYK2 (tyrosine kinase 2), the gene product of which is activated by IFNs, IL-12 and other cytokines, have also been reported to be associated with SLE 126 , providing further evidence in support of the importance of STAT4 in the pathophysiology of this disorder. As the STAT4 polymorphisms do not fall within the coding region of the gene, they presumably influence the level of gene expression, but clearly much more work is required to confirm this hypothesis.
Concluding remarks and future directions
The powerful genome-wide approaches now available to researchers have enabled a comprehensive evaluation of the role of individual STAT proteins in specifying T H cell lineages and a quantitative determination of the target genes that are mobilized during the process of T H cell differentiation. These findings have established that STATs have multiple roles during the initiation stage, as well as the maintenance stage, of a T H cell fate decision. During the maintenance stage, a key role of STATs involves the induction and/or preservation of epigenetic patterns on target gene loci. STAT proteins induce both permissive and repressive epigenetic modifications. Although a particular STAT can be assigned to each T H cell lineage as a dominant regulatory factor, it is clear that this is an overly simplistic way of defining T H cell lineages. Emerging evidence points to the existence of a functional network, in which STATs work both cooperatively and in opposition with each other and with other transcription factors to ensure the desired balance between different T cell fates. In certain cases, this network might also promote phenotypical plasticity.
Fortunately, we now have genome-wide approaches to define the breadth of transcription factor action. In addition, we also have the ability to carry out many chromatin-related assays on a genome-wide scale to examine the activity of genomic regions 127 through common chromatin signatures 128 , and to determine the state of dynamic genomic organization (FIG. 4) . In particular, the extensive coverage of the genome afforded by nextgeneration sequencing offers the possibility of exploring so called 'gene desert' or intergenic regions for distal enhancers and other types of regulatory element 21, 24, 129 . This is an exciting opportunity to analyse previously unexplored regions of the genome and, in fact, recent reports have shown that the patterns of distal enhancers are quite unique and different in different cell types 130 . The challenge now, of course, is to understand how 'master regulators' of cell fate and other transcription factors, such as STATs, contribute to the activity of distal enhancers in a manner that creates cell identity 21, 130 . It is quite possible that some of the polymorphisms that have been linked to autoimmune diseases reside in enhancer regions of the genome 131 that are crucial for regulating tissue-specific patterns of gene expression from a distance.
Equally, the entire notion of the epigenome is in the midst of a not so quiet revolution 27, 132 . Increasingly, epigenetics is being viewed as an extension of signal transduction. Nonetheless, it is certainly not clear how all of the components of epigenetic information are linked to each other, to signalling and to transcription factor binding. Indeed, our understanding of how signal transduction and nucleosome biology are related is really still in its infancy. Because the STAT pathway provides a rapid means of transmitting signals from the extracellular environment to the nucleus, investigating how cytokines drive T H cell specification will provide remarkable opportunities to link signal transduction, transcription factor binding, nucleosome biology and gene expression. Hopefully, valuable new information about gene regulation will come from systematic database analysis of STAT-mediated cytokine signalling in differentiating T cells.
